Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel 5-HT2C agonist shows efficacy in animal models of obesity

March 15, 2005

Pharming expands hereditary angioedema trials of rhC1INH to Canada

March 14, 2005

Clinical studies evaluate the PK profile of febuxostat

March 14, 2005

Aldose reductase inhibitors recommended for diabetic neuropathy

March 14, 2005

Acyline induces long-term gonadotropin, testosterone suppression

March 14, 2005

rhBMP-2 formulation enhances lumbar spine fusion

March 14, 2005

Allograft bone plus rhBMP-2 shows promise in diaphyseal tibial fractures

March 14, 2005

Two series of glucosylceramide synthase inhibitors claimed by Oxford GlycoSciences

March 11, 2005

AVE-0010 completes phase IIa study in type 2 diabetes

March 11, 2005

2MD shows promise as an anabolic agent for the treatment of inadequate bone formation

March 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...